These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 412968)

  • 1. Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
    Barnett CJ; Cullinan GJ; Gerzon K; Hoying RC; Jones WE; Newlon WM; Poore GA; Robison RL; Sweeney MJ; Todd GC; Dyke RW; Nelson RL
    J Med Chem; 1978 Jan; 21(1):88-96. PubMed ID: 412968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of dimeric Catharanthus alkaloids. 2. Experimental antitumor activities of N-substituted deacetylvinblastine amide (vindesine) sulfates.
    Conrad RA; Cullinan GJ; Gerzon K; Poore GA
    J Med Chem; 1979 Apr; 22(4):391-400. PubMed ID: 430477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinblastin-23-oyl amino acid derivatives: chemistry, physicochemical data, toxicity, and antitumor activities against P388 and L1210 leukemias.
    Bhushana Rao KS; Collard MP; Dejonghe JP; Atassi G; Hannart JA; Trouet A
    J Med Chem; 1985 Aug; 28(8):1079-88. PubMed ID: 4020828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
    Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
    Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
    Wilkoff LJ; Dulmadge EA
    J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vindesine: a new vinca alkaloid.
    Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
    Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z; Ochs S
    J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinblastine, Vincristine and Vindesine: anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro.
    Mareel MM; Storme GA; De Bruyne GK; Van Cauwenberge RM
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):199-210. PubMed ID: 7201395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs.
    Todd GC; Gibson WR; Morton DM
    J Toxicol Environ Health; 1976 May; 1(5):843-50. PubMed ID: 1271489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Block of axoplasmic transport in vitro by vinca alkaloids.
    Chan SY; Worth R; Ochs S
    J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of vincristine, vinblastine, and vindesine in rhesus monkeys.
    Sethi VS; Surratt P; Spurr CL
    Cancer Chemother Pharmacol; 1984; 12(1):31-5. PubMed ID: 6690071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.
    Hill BT; Whelan RD
    Cancer Chemother Pharmacol; 1982; 8(2):163-9. PubMed ID: 7105380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
    Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR
    Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor activity of navelbine (vinorelbine ditartrate), a new vinca alkaloid analog].
    Ashizawa T; Miyoshi K; Asada M; Kobayashi E; Okabe M; Morimoto M; Gomi K; Hirata T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):59-66. PubMed ID: 8422187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.
    Nelson RL
    Med Pediatr Oncol; 1982; 10(2):115-27. PubMed ID: 7070351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkaloids of Vinca rosea L. (Catharanthus roseus G. Don). 38. 4'-Dehydrated derivatives.
    Miller JC; Gutowski GE; Poore GA; Boder GB
    J Med Chem; 1977 Mar; 20(3):409-13. PubMed ID: 576619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
    Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacokinetics of vinca alkaloids].
    Rahmani R; Samak R; Bore P; Cano JP
    Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.
    Hill BT; Whelan RD
    J Natl Cancer Inst; 1981 Aug; 67(2):437-43. PubMed ID: 6943380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.